Home » Topics » BioWorld Science

BioWorld Science
RSS

DNA-PKcs inhibitor increases the antitumor activity of localized DNA-damaging therapies

Feb. 28, 2020

Epizyme discloses new SETD2 inhibitors

Feb. 28, 2020

Amgen and Carmot Therapeutics identify USP30 inhibitors

Feb. 28, 2020

Leo Pharma A/S presents RORC ligands

Feb. 28, 2020

Inflazome divulges new NLRP3 inflammasome inhibitors

Feb. 28, 2020

Microglial fresh start helps heal brain trauma

Feb. 28, 2020

Boehringer Ingelheim Pharma patents KLKB1 inhibitors

Feb. 28, 2020

FDA approves IND and grants orphan drug status for HBM-9167

Feb. 28, 2020

CD5.CAR/28zeta CAR T cells show antitumor activity in relapsed/refractory T-cell lymphoma

Feb. 28, 2020

Dosing begins in phase I study of KAN-101 for the treatment of celiac disease

Feb. 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...